ImmuCell Corporation has announced new employment agreements for key executives, effective January 27, 2026. Chief Financial Officer Timothy C. Fiori will receive an annual base salary of $315,000, while Senior Vice President of Sales and Marketing Bobbi Jo Brockmann will receive $300,000. Both executives will be eligible for annual cash bonuses starting in 2026, with target bonus amounts set at 50% of base salary and a potential increase to 60% if all preset financial and strategic targets are exceeded by at least 20%. Additionally, CEO Olivier te Boekhorst has been granted a performance-based stock option to purchase up to 110,000 shares at $6.26 per share, vesting only if the company achieves net operating income targets over four consecutive quarters.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmuCell Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-002685), on February 02, 2026, and is solely responsible for the information contained therein.